{"id":893010,"date":"2025-10-06T21:20:00","date_gmt":"2025-10-07T01:20:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/"},"modified":"2025-10-06T21:20:00","modified_gmt":"2025-10-07T01:20:00","slug":"moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/","title":{"rendered":"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n LOS ANGELES<\/span>
\n <\/span>, Oct. 6, 2025<\/span><\/span> \/PRNewswire\/ — The DJS Law Group<\/a>\u00a0announces that it is investigating claims on behalf of investors of\u00a0MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX<\/a>) for violations of the securities laws.<\/p>\n

\n INVESTIGATION DETAILS: <\/b>The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. MoonLake’s communications to investors about its VELA-2 clinical trial were overly optimistic until September 29, 2025<\/span>, when it announced that “intercurrent events in the higher-than-expected placebo arm precluded the study from achieving statistical significance in the week 16 primary endpoint using the composite strategy (HiSCR75, delta to placebo of 9%.” Based on this news, MoonLake shares suffered a 90% decline in value.<\/p>\n

If you are a shareholder who suffered a loss, contact us to participate<\/a>.<\/p>\n

\n WHY DJS LAW GROUP?<\/b>\u00a0DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\n CONTACT:<\/b>\n <\/p>\n

\n David J. Schwartz<\/span>
\n
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY<\/span> 10709
Phone: 914-206-9742
Email: David@djslawllp.com<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations—contact-the-djs-law-group-to-discuss-your-rights–mltx-302576384.html<\/a><\/p>\n

SOURCE DJS Law Group LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire LOS ANGELES , Oct. 6, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0announces that it is investigating claims on behalf of investors of\u00a0MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. MoonLake’s communications to investors about its VELA-2 clinical trial were overly optimistic until September 29, 2025, when it announced that “intercurrent events in the higher-than-expected placebo arm precluded the study from achieving statistical significance in the week 16 primary endpoint using the composite strategy (HiSCR75, delta to placebo of 9%.” Based on this news, MoonLake shares suffered a 90% decline in value. If … <\/p>\n

Continue reading “MoonLake Immunotherapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-893010","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES , Oct. 6, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0announces that it is investigating claims on behalf of investors of\u00a0MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. MoonLake’s communications to investors about its VELA-2 clinical trial were overly optimistic until September 29, 2025, when it announced that “intercurrent events in the higher-than-expected placebo arm precluded the study from achieving statistical significance in the week 16 primary endpoint using the composite strategy (HiSCR75, delta to placebo of 9%.” Based on this news, MoonLake shares suffered a 90% decline in value. If … Continue reading "MoonLake Immunotherapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-07T01:20:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA90804&sd=2025-10-06\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX\",\"datePublished\":\"2025-10-07T01:20:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LA90804&sd=2025-10-06\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/\",\"name\":\"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LA90804&sd=2025-10-06\",\"datePublished\":\"2025-10-07T01:20:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LA90804&sd=2025-10-06\",\"contentUrl\":\"https:\\\/\\\/edge.prnewswire.com\\\/c\\\/img\\\/favicon.png?sn=LA90804&sd=2025-10-06\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/","og_locale":"en_US","og_type":"article","og_title":"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk","og_description":"PR Newswire LOS ANGELES , Oct. 6, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0announces that it is investigating claims on behalf of investors of\u00a0MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. MoonLake’s communications to investors about its VELA-2 clinical trial were overly optimistic until September 29, 2025, when it announced that “intercurrent events in the higher-than-expected placebo arm precluded the study from achieving statistical significance in the week 16 primary endpoint using the composite strategy (HiSCR75, delta to placebo of 9%.” Based on this news, MoonLake shares suffered a 90% decline in value. If … Continue reading \"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-07T01:20:00+00:00","og_image":[{"url":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA90804&sd=2025-10-06","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX","datePublished":"2025-10-07T01:20:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/#primaryimage"},"thumbnailUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA90804&sd=2025-10-06","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/","name":"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/#primaryimage"},"thumbnailUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA90804&sd=2025-10-06","datePublished":"2025-10-07T01:20:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/#primaryimage","url":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA90804&sd=2025-10-06","contentUrl":"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA90804&sd=2025-10-06"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/moonlake-immunotherapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-mltx-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MoonLake Immunotherapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/893010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=893010"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/893010\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=893010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=893010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=893010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}